A chemical-biological study reveals C9-type iridoids as novel heat shock protein 90 (Hsp90) inhibitors

Dal Piaz, F; Vassallo, A; Temraz, A; Cotugno, R; Belisario, MA; Bifulco, G; Chini, MG; Pisano, C; De Tommasi, N; Braca, A

HERO ID

2901889

Reference Type

Journal Article

Year

2013

Language

English

PMID

23362862

HERO ID 2901889
In Press No
Year 2013
Title A chemical-biological study reveals C9-type iridoids as novel heat shock protein 90 (Hsp90) inhibitors
Authors Dal Piaz, F; Vassallo, A; Temraz, A; Cotugno, R; Belisario, MA; Bifulco, G; Chini, MG; Pisano, C; De Tommasi, N; Braca, A
Journal Journal of Medicinal Chemistry
Volume 56
Issue 4
Page Numbers 1583-1595
Abstract The potential of heat shock protein 90 (Hsp90) as a therapeutic target for numerous diseases has made the identification and optimization of novel Hsp90 inhibitors an emerging therapeutic strategy. A surface plasmon resonance (SPR) approach was adopted to screen some iridoids for their Hsp90 α binding capability. Twenty-four iridoid derivatives, including 13 new natural compounds, were isolated from the leaves of Tabebuia argentea and petioles of Catalpa bignonioides. Their structures were elucidated by NMR, electrospray ionization mass spectrometry, and chemical methods. By means of a panel of chemical and biological approaches, four iridoids were demonstrated to bind Hsp90 α. In particular, the dimeric iridoid argenteoside A was shown to efficiently inhibit the chaperone in biochemical and cellular assays. Our results disclose C9-type iridoids as a novel class of Hsp90 inhibitors.
Doi 10.1021/jm301398y
Pmid 23362862
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English